An Observational, Multicenter Study Evaluating the Safety of ReAl-lifePertuzumab and Trastuzumab Fixed Dose Combination: the RAPID Study

NCT06835348 · clinicaltrials.gov ↗
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fondazione Oncotech